Tim Greten, MD
Enriched profileSenior Investigator, Center for Cancer Research, National Cancer Institute; CCR Deputy Director · National Institutes of Health
Tim Greten is Senior Investigator, Center for Cancer Research, National Cancer Institute; CCR Deputy Director at National Institutes of Health. OpenAlex indexes 569 publications with 54,882 citations (h-index 89); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 23 Oct 2026
Tim Greten, M.D., is Senior Investigator, Center for Cancer Research, National Cancer Institute at National Institutes of Health. The public record shows 569 publications with 54,882 citations (h-index 89), centered on Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Immunotherapy and Immune Responses. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 5 companies.
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Cancer Immunotherapy and Biomarkers
- 23 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 245.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
Sponsor: National Cancer Institute (NCI)
- A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Sponsor: National Cancer Institute (NCI)
- GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 23 Oct 2026
5 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20251 payment
- AstraZeneca UK LimitedProgram year20245 payments
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 23 Oct 2026
93 congress contributions (2006–2026) across AACR, ASCO per OpenAlex. The most recent:
- Abstract 1585: Kinetic profiling of ILC and ILTC responses during early hepatocellular carcinoma development reveals IL-15-ILC1 axis
AACR Annual Meeting
AACR2026Co-author - Treatment of Advanced Biliary Tract Cancer: ASCO Living Guideline, Version 2026.1.0
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Treatment of Advanced Biliary Tract Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology
Article2026 - Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?
Nature reviews. Clinical oncology
Article2026 - Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.
Clinical cancer research
Article2026 - Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.
Journal for immunotherapy of cancer
Article2025 - SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases.
Nature communications
Article2025
Most-cited works
by citation count (OpenAlex)- 01Sorafenib in Advanced Hepatocellular CarcinomaArticle13,093 citations2008
- 02Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeArticle6,616 citations2017
- 03Recommendations for myeloid-derived suppressor cell nomenclature and characterization standardsArticle2,737 citations2016
- 04IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated CancerArticle2,431 citations2004
- 05Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cellsArticle1,508 citations2018
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biography.omicsonline.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
- Postdoctoral Fellowship
Johns Hopkins University, Baltimore
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
Editorial & leadership roles
journal and society appointments- Chairperson
CCR Scientific Protocol Review
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cholangiocarcinoma.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
- Co-director
NCI Center for Cancer Research Liver Cancer Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗ - Co-chair
Center of Excellence in Immunology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biography.omicsonline.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Joel Moss, MD
National Institutes of Health
Lynnette Nieman, MD
National Institutes of Health
Steven Pavletic, MD
National Institutes of Health
Theo Heller, MD
National Institutes of Health
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH